Inhibitors of melanogenesis increase toxicity of cyclophosphamide and lymphocytes against melanoma cells.
about
Development and external validation of a prognostic nomogram for metastatic uveal melanomaSt John's Wort (Hypericum perforatum L.) photomedicine: hypericin-photodynamic therapy induces metastatic melanoma cell deathUveal melanoma cells utilize a novel route for transendothelial migrationEffects of Ganodermanondiol, a New Melanogenesis Inhibitor from the Medicinal Mushroom Ganoderma lucidumDaphnane diterpene hirsein B downregulates melanogenesis in B16 murine melanoma cells by cAMP pathway inhibitionNovel vitamin D analogs as potential therapeutics: metabolism, toxicity profiling, and antiproliferative activity.The proliferation of malignant melanoma cells could be inhibited by ranibizumab via antagonizing VEGF through VEGFR1.Stable synthetic bacteriochlorins overcome the resistance of melanoma to photodynamic therapy.Sensing the environment: regulation of local and global homeostasis by the skin's neuroendocrine system.Key role of CRF in the skin stress response system.Therapy preferences in melanoma treatment--willingness to pay and preference of quality versus length of life of patients, physicians and healthy controls.The role of melanogenesis in regulation of melanoma behavior: melanogenesis leads to stimulation of HIF-1α expression and HIF-dependent attendant pathways.IL28B polymorphism cannot predict response to interferon alpha treatment in patients with melanoma.Current concepts of metastasis in melanoma.Expression of vitamin D receptor decreases during progression of pigmented skin lesions.Immunomodulatory effects of sex hormones: requirements for pregnancy and relevance in melanoma.Melatonin and its metabolites accumulate in the human epidermis in vivo and inhibit proliferation and tyrosinase activity in epidermal melanocytes in vitro.Oral mucosal melanoma: some pathobiological considerations and an illustrative report of a caseN1-Acetyl-5-Methoxykynuramine (AMK) is produced in the human epidermis and shows antiproliferative effects.Antitumor effects of vitamin D analogs on hamster and mouse melanoma cell lines in relation to melanin pigmentation.L-tyrosine and L-dihydroxyphenylalanine as hormone-like regulators of melanocyte functionsHyperpigmentation Results in Aberrant Immune Development in Silky Fowl (Gallus gallus domesticus Brisson)Targeting protein-trafficking pathways alters melanoma treatment sensitivity.The Effect of Electroporation of a Lyotroic Liquid Crystal Genistein-Based Formulation in the Recovery of Murine Melanoma Lesions.Clinical Characteristics of 582 Patients with Uveal Melanoma in China.Insulin-Like Growth Factor II mRNA-Binding Protein 3 Expression Correlates with Poor Prognosis in Acral Lentiginous Melanoma.Comparison of the Lonidamine Potentiated Effect of Nitrogen Mustard Alkylating Agents on the Systemic Treatment of DB-1 Human Melanoma Xenografts in MicePD-1 Antibody Monotherapy for Malignant Melanoma: A Systematic Review and Meta-AnalysisClinical Characteristics of Malignant Melanoma in Southwest China: A Single-Center Series of 82 Consecutive Cases and a Meta-Analysis of 958 Reported CasesEradication of melanoma in vitro and in vivo via targeting with a Killer-Red-containing telomerase-dependent adenovirus.Deep-proteome mapping of WM-266-4 human metastatic melanoma cells: From oncogenic addiction to druggable targetsCombined regimen of photodynamic therapy mediated by Gallium phthalocyanine chloride and Metformin enhances anti-melanoma efficacyExpression of the vitamin D-activating enzyme 1α-hydroxylase (CYP27B1) decreases during melanoma progressionMetabolism of melatonin and biological activity of intermediates of melatoninergic pathway in human skin cells.Melanin content in melanoma metastases affects the outcome of radiotherapy.Melanogenesis affects overall and disease-free survival in patients with stage III and IV melanoma.Growth inhibition of re-challenge B16 melanoma transplant by conjugates of melanogenesis substrate and magnetite nanoparticles as the basis for developing melanoma-targeted chemo-thermo-immunotherapy.RORα and RORγ expression inversely correlates with human melanoma progression.Molecular networks in melanoma invasion and metastasis.Putative role of HIF transcriptional activity in melanocytes and melanoma biology.
P2860
Q21131800-C6304636-6E50-4FE9-BEF2-7A685536631EQ21131978-1C7B1C2F-F6F5-4B79-B6C3-4D32DA3544FAQ27319660-0E74128C-E186-407C-9692-816BA455F3E6Q28818124-58471BAF-4195-4744-851B-572B9DBA9C44Q30395542-781CEFB9-9181-454A-BCC5-1E3584019001Q33588771-449698D7-310B-4516-951D-8367BAFCE650Q33614283-04B2315D-4ADC-4254-983E-CD8076848D68Q34072225-642FEE7E-B9BA-4EE2-892C-0BAD512EE96AQ34294075-58FA023B-FD30-4CB5-A47B-423BAF98DB42Q34363640-0354D04D-ECFB-4C94-9081-9A56D12286B7Q34450266-2DAF86C6-F02F-41D7-B584-90E4E6A22E61Q34459021-6B242868-40DF-437E-AEB5-75A9DC2EE27EQ34497983-9CC47E46-56C3-4195-B6E6-49A349489A2FQ34610427-9D711BB9-7AAF-4DA2-9D68-869B9DFA4700Q34803691-FEA70A78-59E3-4821-AB48-D861EED9CEB1Q34855293-3BF77683-9D2E-4AB5-9E9D-73944A3FE221Q35130860-CE5E5818-4E6C-43C3-B158-AB077A23091AQ35243932-431472B3-4287-4415-A643-B1183C4BF1E9Q35436151-54E8BC6E-C08D-4C91-9FCD-FB8D3FB4276AQ35585386-7DD2505E-92C5-472C-9AEB-C7A6328B4466Q35624374-A736568F-169A-41F9-9863-45DC0DE88BA1Q35654447-2458199B-AD0E-4F57-AF5D-31EE41016B8FQ35673847-BA0E8331-5958-4527-AA9C-745D3E6D195CQ35694032-18C2A171-F099-40FF-890D-2A008E595F8BQ35863197-2465174C-8E7F-4FEC-ABA4-B4965D02A329Q35900481-0F23C61E-283C-49D0-B6C7-0E7A3F183F11Q36048258-AC93213B-FFFC-4492-B03A-9B6772D66AEBQ36092580-29028EDB-9636-4AF8-AC3A-34BE3839DF8FQ36197056-9D20FDCB-268A-426B-B67F-60D78121E6E5Q36240189-6AD61504-0062-4BB6-B121-8619B69DF9EDQ36270042-C29ADE80-EF2D-4AA8-B539-085E4E7339F9Q36302221-A750429B-3D44-43DD-AB5A-3BD754B5F074Q36487466-DC3B2B44-5308-4049-BFB5-BC32801909BFQ36945150-E6B27534-5315-48E0-A493-7745760F3FB9Q37109611-9D614EFB-7EA9-47F6-A6B2-99FE5771EC06Q37198853-0EB92775-39FB-452D-9790-3E3CC0725FF5Q37383547-49A800CE-513E-448E-AB65-87E53FBA2CB2Q37665305-DD6F3760-9BC2-4539-AC8F-CE52A977CFBDQ38104416-F7B25FD8-F0FC-427C-86DC-64771A3A0B11Q38160223-B9FAE6D4-224F-4069-9595-4BABC03022C2
P2860
Inhibitors of melanogenesis increase toxicity of cyclophosphamide and lymphocytes against melanoma cells.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Inhibitors of melanogenesis in ...... ocytes against melanoma cells.
@en
Inhibitors of melanogenesis in ...... ocytes against melanoma cells.
@nl
type
label
Inhibitors of melanogenesis in ...... ocytes against melanoma cells.
@en
Inhibitors of melanogenesis in ...... ocytes against melanoma cells.
@nl
prefLabel
Inhibitors of melanogenesis in ...... ocytes against melanoma cells.
@en
Inhibitors of melanogenesis in ...... ocytes against melanoma cells.
@nl
P2860
P356
P1476
Inhibitors of melanogenesis in ...... ocytes against melanoma cells.
@en
P2093
Blazej Zbytek
Radomir Slominski
P2860
P304
P356
10.1002/IJC.24005
P577
2009-03-01T00:00:00Z